# Effect of Triple Versus Quadruple Therapy for Treating Helicobacter Pylori Infection

> **NCT07010744** · NA · ENROLLING_BY_INVITATION · sponsor: **Akil Al Islam** · enrollment: 66 (estimated)

## Conditions studied

- Dyspepsia

## Interventions

- **DRUG:** Triple drug regimen
- **DRUG:** Quadruple therapy

## Key facts

- **NCT ID:** NCT07010744
- **Lead sponsor:** Akil Al Islam
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2025-07-01
- **Primary completion:** 2026-06
- **Final completion:** 2026-06
- **Target enrollment:** 66 (ESTIMATED)
- **Last updated:** 2026-05-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07010744

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07010744, "Effect of Triple Versus Quadruple Therapy for Treating Helicobacter Pylori Infection". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT07010744. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*